Stryker Corporation completed the acquisition of NOVADAQ Technologies, a leading developer of fluorescence imaging technology that provides surgeons with visualization of blood flow in vessels, and related tissue perfusion in cardiac, cardiovascular, gastrointestinal, plastic, microsurgical, and reconstructive procedures.
The transaction is expected to be dilutive to Stryker's 2017 adjusted net earnings per diluted share by
USD 0.03–0.05.

10 Diagnostic Imaging Trends for 2018



Digital version